Name: The Market for Contract Manufacturing in In Vitro Diagnostics (IVD)
SKU: 22-706
Availability: InStock

Description

The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to:

expand existing product lines
broaden access to IVD testing technologies
increase access to manufacturing capacity without capital investment
quickly introduce tests and testing systems for newly emerging diseases and disorders (e.g., COVID-19, Monkeypox, etc.)
gain support for regulatory filings
penetrate high growth applications especially in the area of point-of-care (POC) testing
meet the specialized testing needs of major end users

Contract manufacturing also enables new and smaller IVD producers to build up product lines and increase competitiveness in the marketplace. Moreover, the segment is the major source of private label tests, instruments, and accessories sold by medical supply and device distributors, home healthcare outlets, and drug stores. Private label applications have expanded considerably over the past few years largely due to the impact of the COVID-19 pandemic.

Scope and Methodology

This report examines global trends in the contract IVD manufacturing business. The analysis is divided into:

technology (immunoassay, clinical chemistry, molecular assays, microbiology, hematology, histology/cytology, coagulation, blood grouping, and other),
product (reagents and test kits, instruments and systems, and accessories),
and end-use applications (point-of-care and clinical laboratory).

The report also discusses contract IVD services in non-manufacturing areas such as assay development, instrument design, regulatory filings, and packaging.

Principal customers for contract IVD manufacturing and non-manufacturing services include traditional IVD product producers, medical supply distributors, drug stores and mass merchandisers, and Internet and mail order enterprises. Global revenues generated by these services are expressed in current United States dollars and reflect estimates for the year 2021 and forecasts for each year in the 2022 to 2026 period.

Chapter 1: Executive Summary

Global Market Outlook – Contract IVD Manufacturing

Table 1-1: Summary Table – Global Contract IVD Manufacturing Market, 2021-2026 (million dollars)

Scope and Methodology

Chapter 2: Market Environment

Overview

Global Economic Outlook

Table 2-1: Gross Domestic Product by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (billion dollars)

Per Capita Gross Domestic Product

Table 2-2: Per Capita Gross Domestic Product by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (dollars)

Population

Table 2-3: Population by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)

Age Distribution

Population 50 Years & Older

Table 2-4: Population 50 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)
Table 2-5: Percentage of Population 50 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)

Population 65 Years & Older

Table 2-6: Population 65 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)
Table 2-7: Percentage of Population 65 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)

Global Healthcare Trends

Medical Conditions

Health Expenditures

Table 2-8: Health Expenditures by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (billion dollars)
Table 2-9: Per Capita Health Expenditures by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (dollars)

Hospital Beds

Table 2-10: Number of Hospital Beds by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-11: Number of Hospital Beds Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Physicians

Table 2-12: Number of Practicing Physicians by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-13: Number of Practicing Physicians Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Patient Activity

Acute Care Hospital Admissions

Table 2-14: Number of Acute Care Hospital Admissions by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-15: Number of Acute Care Hospital Admissions Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Surgical Procedures

Table 2-16: Number of Surgical Procedures by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-17: Number of Surgical Procedures Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Physicians’ Consultations

Table 2-18: Number of Physicians’ Consultations by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (millions)
Table 2-19: Number of Physicians’ Consultations Per Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

IVD Tests

Table 2-20: Number of IVD Tests by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (millions)
Table 2-21: Number of IVD Tests Per Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Chapter 3: IVD Products

Industry Overview

Table 3-1: Global IVD Product Demand by Technology (Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

IVD Product Demand by Technology

Immunoassays

Clinical Chemistry

Molecular IVD Technology

Microbiology

Hematology

Coagulation

Histology/Cytology

Blood Grouping

Other IVD Technologies

Product Groups

Table 3-2: Global IVD Demand by Product Group (Reagents & Test Kits, Instruments & Systems, Supplies & Accessories), 2021-2026 (million dollars)

IVD Reagents & Test Kits

Table 3-3: Global IVD Reagents & Test Kits Demand by Technology (Point-of-Care, Clinical Laboratory, Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

IVD Instruments & Systems

Table 3-4: Global IVD Instruments & Systems Demand by Technology (Point-of-Care, Clinical Laboratory, Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

IVD Supplies & Accessories

Table 3-5: Global IVD Supplies & Accessories Demand by Technology (Point-of-Care, Clinical Laboratory, Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

Production by Region

Table 3-6: Global IVD Production Value by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million dollars)

Chapter 4: Contract IVD Manufacturing

Market Overview

Market Forecast

Table 4-1: Global Contract IVD Manufacturing Demand by Technology (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million dollars)

Regional Trends

Table 4-2: Global Contract IVD Manufacturing Demand by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million dollars)

Product Groups

Table 4-3: Global Contract IVD Manufacturing Demand by Product Group (Reagents & Test Kits, Instruments & Systems, and Supplies & Accessories), 2021-2026 (million dollars)

Contract Immunoassay Products

Overview

Types of Immunoassays